Kip A. West

6.9k citations

30 papers · 4.9k indexed · 5 hit papers · h-index 22

Impact in

Biotechnology top 0.5%
- Cancer Research and Treatments
Molecular Biology top 2%
- PI3K/AKT/mTOR signaling in cancer
- Gut microbiota and health
- Nicotinic Acetylcholine Receptors Study
- Protein Kinase Regulation and GTPase Signaling

Papers in

Immunology and Allergy 3
- Cell Adhesion Molecules Research 3
Biotechnology 4
- Cancer Research and Treatments 4

Co-authors: Phillip A. Dennis Amy S. Clark S. Sianna Castillo Samantha A. Streicher Curtis C. Harris Steven A. Belinsky Ilona Linnoila Christopher E. Turner
Journals: Cancer Research (7 papers)Molecular Cancer Therapeutics (2 papers)Journal of Clinical Investigation (2 papers)Current Topics in Medicinal Chemistry (1 paper)The Journal of Cell Biology (1 paper)
Partner nations: United States Switzerland Canada

In The Last Decade

Kip A. West

29 papers receiving 4.8k citations

Hit Papers

5 papers align trajectories log scale

Metabolic modulation of tumours with engineered bacteria for immunotherapy 2021 · 419 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Nature
2020 Nature Communications
2019 Science Translational Medicine
2018 Nature Biotechnology
2002 PubMed

Peers

Countries citing papers authored by Kip A. West

Since Specialization

Citations

This map shows the geographic impact of Kip A. West's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kip A. West with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kip A. West more than expected).

Fields of papers citing papers by Kip A. West

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kip A. West. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kip A. West. The network helps show where Kip A. West may publish in the future.

Co-authors

The 25 scholars most cited alongside Kip A. West, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kip A. West Line = papers co-authored together Kip A. West links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Abstract 1751: Beta catenin c-mods are orally bioavailable small-molecules targeting Wnt-driven tumors Cancer Research ·Isaac A. Klein, Kip A. West, Douglas Baumann, Adam Talbot, Thomas F. Durand-Réville, Karl Hsu, Ann Boija	2025	0
2	Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity Nature Communications ·Daniel S. Leventhal, Anna Sokolovska, Ning Li, Christopher Plescia, Starsha Kolodziej, Carey W. Gallant, Rudy Christmas, Jianrong Gao, Michael J. James, Andrés Abín-Fuentes, Munira Momin, Christopher G Bergeron, Adam Fisher, Paul Miller, Kip A. West, José M. Lora Hit paper breakdown →	2020	326
3	An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans Science Translational Medicine ·Caroline Kurtz, Yves Millet, Marja Puurunen, Mylène Perreault, Mark R. Charbonneau, Vincent M. Isabella, Jonathan W. Kotula, Eugene Antipov, Yossi Dagon, William S. Denney, David A. Wagner, Kip A. West, Andrew J. Degar, Aoife M. Brennan, Paul Miller Hit paper breakdown →	2019	280
4	Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria Nature Biotechnology ·Vincent M. Isabella, Binh Ha, Mary Joan Castillo, David Lubkowicz, Sarah E. Rowe, Yves Millet, Cami Anderson, Ning Li, Adam Fisher, Kip A. West, Philippa J. Reeder, Munira Momin, Christopher G Bergeron, Sarah E. Guilmain, Paul Miller, Caroline Kurtz, Dean Falb Hit paper breakdown →	2018	403
5	Abstract LB-131: Activation of innate and adaptive immunity via combinatorial immunotherapy using Synthetic Biotic™ Medicines Cancer Research ·Daniel S. Leventhal, Kip A. West, Adam Fisher, Anna Sokolovska, Starsha Kolodziej, Ning Li, Chris Plescia, Carey W. Gallant, Mary Joan Castillo, Paul Miller, José M. Lora	2018	2
6	Abstract 2920: Metabolic modulation of the tumor microenvironment using Synthetic Biotic™ Medicines Cancer Research ·Kip A. West, Adam Fisher, Dan Leventhal, Anna Sokolovska, Ning Li, Chris Plescia, Mary Joan Castillo, Vincent M. Isabella, Starsha Kolodziej, Paul Miller, José M. Lora	2018	5
7	HSP90 Inhibition Enhances Antimitotic Drug-Induced Mitotic Arrest and Cell Death in Preclinical Models of Non-Small Cell Lung Cancer PLoS ONE ·Brenda O’Connell, Katie O’Callaghan, Bonnie Tillotson, Mark Douglas, Nafeeza Hafeez, Kip A. West, Howard M. Stern, Janid A. Ali, Paul S. Changelian, Christian Fritz, Vito J. Palombella, Karen McGovern, Jeffery L. Kutok	2014	14
8	Hedgehog-Gli Pathway Activation during Kidney Fibrosis American Journal Of Pathology ·Steven Fabian, Radostin Penchev, Benoit St‐Jacques, Anjali Rao, Petra Sipilä, Kip A. West, Andrew P. McMahon, Benjamin D. Humphreys	2012	169
9	Antitumor Activity of the Hsp90 Inhibitor IPI-504 in HER2-Positive Trastuzumab-Resistant Breast Cancer Molecular Cancer Therapeutics ·Maurizio Scaltriti, Violeta Serra, Emmanuel Normant, Marta Guzmán, Olga Rodríguez, Alice R. Lim, Kelly L. Slocum, Kip A. West, Varenka Rodriguez, Ludmila Prudkin, José Jiménez, Claudia Aura, José Baselga	2011	44
10	The Hsp90 inhibitor IPI-504 rapidly lowers EML4–ALK levels and induces tumor regression in ALK-driven NSCLC models Oncogene ·Emmanuel Normant, Guillermo Paez, Kip A. West, Alice R. Lim, Kelly L. Slocum, Chris Tunkey, James K. McDougall, Andrew A. Wylie, Keith Robison, K. Caliri, Vito J. Palombella, Christian Fritz	2011	126
11	Hsp90 (Heat Shock Protein 90) Inhibitor Occupancy Is a Direct Determinant of Client Protein Degradation and Tumor Growth Arrest in Vivo Journal of Biological Chemistry ·Bonnie Tillotson, Kelly L. Slocum, John Coco, Nigel Whitebread, Brian D. Thomas, Kip A. West, John R. MacDougall, Jie Ge, Janid A. Ali, Vito J. Palombella, Emmanuel Normant, Julian Adams, Christian Fritz	2010	37
12	Ansamycin Inhibitors of Hsp90: Natures Prototype for Anti-Chaperone Therapy Current Topics in Medicinal Chemistry ·James R. Porter, Jie Ge, J. Jack Lee, Emmanuel Normant, Kip A. West	2009	55
13	Tobacco Carcinogen-Induced Cellular Transformation Increases Akt Activation In Vitro and In Vivo CHEST Journal ·Kip A. West, Ilona Linnoila, John Brognard, Steven A. Belinsky, Curtis C. Harris, Phillip A. Dennis	2004	10
14	Tobacco Carcinogen-Induced Cellular Transformation Increases Activation of the Phosphatidylinositol 3′-Kinase/Akt Pathwayin Vitroandin Vivo Cancer Research ·Kip A. West, Ilona Linnoila, Steven A. Belinsky, Curtis C. Harris, Phillip A. Dennis	2004	107
15	Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells Journal of Clinical Investigation ·Kip A. West, John Brognard, Amy S. Clark, Ilona Linnoila, Xiaowei Yang, Sandra M. Swain, Curtis C. Harris, Steven A. Belinsky, Phillip A. Dennis	2003	437
16	Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells Journal of Clinical Investigation ·Kip A. West, John Brognard, Amy S. Clark, Ilona Linnoila, Xiaowei Yang, Sandra M. Swain, Curtis C. Harris, Steven A. Belinsky, Phillip A. Dennis	2003	415
17	Activation of the PI3K/Akt pathway and chemotherapeutic resistance Drug Resistance Updates ·Kip A. West, S. Sianna Castillo, Phillip A. Dennis	2002	496
18	Paxillin-dependent Paxillin Kinase Linker and p21-Activated Kinase Localization to Focal Adhesions Involves a Multistep Activation Pathway Molecular Biology of the Cell ·Michael C. Brown, Kip A. West, Christopher E. Turner	2002	144
19	Paxillin–ARF GAP signaling and the cytoskeleton Current Opinion in Cell Biology ·Christopher E. Turner, Kip A. West, Michael C. Brown	2001	111
20	The LD4 motif of paxillin regulates cell spreading and motility through an interaction with paxillin kinase linker (PKL) The Journal of Cell Biology ·Kip A. West, Huaye Zhang, Michael C. Brown, Sotiris N. Nikolopoulos, M.C. Riedy, Alan F. Horwitz, Christopher E. Turner	2001	145

About Kip A. West

Kip A. West is a scholar working on Immunology and Allergy, Biotechnology, Biological Psychiatry, Molecular Biology and Clinical Biochemistry, having authored 30 papers that have together received 4.9k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (9 papers), Heat shock proteins research (6 papers), Cancer Research and Treatments (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), Cancer Mechanisms and Therapy (4 papers), Cell Adhesion Molecules Research (3 papers), Cellular Mechanics and Interactions (3 papers) and Metabolism and Genetic Disorders (2 papers). The work is most often cited by research in Biotechnology (571 citations), Molecular Biology (3.4k citations), Immunology and Allergy (243 citations), Oncology (1.1k citations) and Cancer Research (448 citations). Kip A. West has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Phillip A. Dennis, Amy S. Clark, S. Sianna Castillo, Samantha A. Streicher, Curtis C. Harris, Steven A. Belinsky, Ilona Linnoila, Christopher E. Turner, Michael C. Brown and John Brognard. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Journal of Clinical Investigation, Current Topics in Medicinal Chemistry and The Journal of Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact